A real-life study on everolimus plus exemestane therapy in a cohort of HR-positive, HER2-negative postmenopausal advanced breast cancer patients; A study of the SOutheast Netherlands Advanced BREast cancer (SONABRE) Registry

2018 ◽  
Vol 92 ◽  
pp. S113
Author(s):  
L.M. Knapen ◽  
S.M.E. Geurts ◽  
M. De Boer ◽  
S. Croes ◽  
K.I.E. Ibragimova ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Cancer Patients ◽  
Real Life ◽  
Advanced Breast ◽  
Breast Cancer Patients ◽  
Life Study ◽  
Real Life Study

Real-life effectiveness of T-DM1 in heavily pretreated HER2-positive advanced breast cancer patients: An Italian observational study.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e12019-e12019 ◽  
Author(s):  
Alessandra Fabi ◽  
Katia Cannita ◽  
Gianluigi Ferretti ◽  
Mariangela Ciccarese ◽  
Grazia Arpino ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Observational Study ◽  
Advanced Breast Cancer ◽  
Cancer Patients ◽  
Real Life ◽  
Advanced Breast ◽  
Breast Cancer Patients ◽  
Her2 Positive ◽  
Life Effectiveness ◽  
Heavily Pretreated

Efficacy and Toxicity of Eribulin in Real-Life Non-Selected Advanced Breast Cancer Patients

The Breast ◽  
2017 ◽  
Vol 36 ◽  
pp. S52-S53
Author(s):  
Anne Sofie Brems-Eskildsen ◽  
Kristina Bak Kristoffersen ◽  
Soeren Linnet ◽  
Tamás Lörincz ◽  
Sven Tyge Langkjer
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Cancer Patients ◽  
Real Life ◽  
Advanced Breast ◽  
Breast Cancer Patients

scholarly journals Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients

2007 ◽  
Vol 9 (4) ◽  
Author(s):  
Javier Silva ◽  
Vanesa García ◽  
José M García ◽  
Cristina Peña ◽  
Gemma Domínguez ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Prognostic Factor ◽  
Advanced Breast Cancer ◽  
Cancer Patients ◽  
Advanced Breast ◽  
Breast Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document